Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Investigating microemboli clearance in a mouse model of Alzheimer's disease

EF 2023-24

Résumé
Cerebral microinfarcts, which often go undetected, occur when microemoli obstruct small blood vessels in the brain, interrupting blood flow. These lesions, ranging from 100um to 3mm, are thought to silently accumulate with age, amassing hundreds to thousands over a lifetime. Microinfarcts contribute to cognitive decline and are particularly prevalent in the dementia population, with a significant 43% of Alzheimer's patients presenting with these lesions. Alzheimer's disease (AD) is characterized by the accumulation of abnormal plaques and neurofibrillary tangles, often accompanied by cerebrovascular changes, such as amyloid angiopathy, the buildup of beta-amyloid peptides in vessel walls. These AD-derived cerebrovascular abnormalities may play a critical role in microinfarct formation and subsequent cognitive decline. Vascular responses to blockages, such as angiophagy, where vessels expel microemboli to restore blood flow, are crucial in mitigating the damage caused by vessel obstruction. In rodent models, this process has been shown to occur over the course of seven days. To date, the dynamics of angiophagy in the context of AD pathology remain unexplored. To investigate the relationship between microinfarcts and AD, we will induce microinfarcts in mouse model of AD - 3xTg. Using fluorescent imaging, this novel study aims to quantify brain-wide damage instigated by microvessel obstruction and determine if AD-pathology disrupts the typical time course of microemboli clearance. Our novel study will be the first to evaluate angiophagy in the context of AD on a brain-wide scale, adding significant value to a critical area of research.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506112
Name
Haugen Fiona O
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating microemboli clearance in a mouse model of Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Angiophagy; Blood Brain Barrier; Microinfarcts; Vasculature
Abstract
Cerebral microinfarcts, which often go undetected, occur when microemoli obstruct small blood vessels in the brain, interrupting blood flow. These lesions, ranging from 100um to 3mm, are thought to silently accumulate with age, amassing hundreds to thousands over a lifetime. Microinfarcts contribute to cognitive decline and are particularly prevalent in the dementia population, with a significant 43% of Alzheimer's patients presenting with these lesions. Alzheimer's disease (AD) is characterized by the accumulation of abnormal plaques and neurofibrillary tangles, often accompanied by cerebrovascular changes, such as amyloid angiopathy, the buildup of beta-amyloid peptides in vessel walls. These AD-derived cerebrovascular abnormalities may play a critical role in microinfarct formation and subsequent cognitive decline. Vascular responses to blockages, such as angiophagy, where vessels expel microemboli to restore blood flow, are crucial in mitigating the damage caused by vessel obstruction. In rodent models, this process has been shown to occur over the course of seven days. To date, the dynamics of angiophagy in the context of AD pathology remain unexplored. To investigate the relationship between microinfarcts and AD, we will induce microinfarcts in mouse model of AD - 3xTg. Using fluorescent imaging, this novel study aims to quantify brain-wide damage instigated by microvessel obstruction and determine if AD-pathology disrupts the typical time course of microemboli clearance. Our novel study will be the first to evaluate angiophagy in the context of AD on a brain-wide scale, adding significant value to a critical area of research.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Haugen, Fiona O
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~